Tirzepatide | US Warehouse | GLP-1 Peptides GIP GCG | 99% PTR10 TR15 TR20mg TR60mgurity | Vials | Lyophilized Powder/2023788-19-2research peptide who

These products are APIs (Active Pharmaceutical Ingredient) and not a finished drug. 

It is intended strictly for research and laboratory use only.

Buyers are required to fully comply with all applicable laws and regulations regarding the handling and use of this material.

Tirzepatide  is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.

1. Ultra-High Purity
Each batch is synthesized and purified to >99% purity (HPLC), ensuring reliable and reproducible results in sensitive experiments.

2.Accurate Dosing & Consistency
Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Batch-to-batch consistency is rigorously maintained.

3.Endotoxin-Free & Sterile Processing
Manufactured in a cleanroom environment, our peptides are free from endotoxins, microbial contamination, and other impurities that could interfere with cell-based or in vivo studies.

1. Superior Product Quality

Product quality is the foundation of our business.  Peptides are synthesized using solid-phase peptide synthesis (SPPS), then purified through HPLC and confirmed by mass spectrometry (MS).

Each batch includes a Certificate of Analysis (COA) with key data:
• Purity (HPLC)
• Molecular weight (MS)
• Water content
• Residual solvents
• Microbial limit (if applicable)

For clients with higher regulatory demands, we also provide third-party testing reports, endotoxin (LAL) data, and stability studies upon request.

2. Customization & R&D Support

We offer flexible custom synthesis services, supported by an experienced R&D team. Whether you’re looking for novel peptide sequences, cosmetic-grade purity, or modified molecules (e.g., PEGylation, acetylation), we can deliver high-quality results on time.

Our services include:
• Custom peptide synthesis (mg to kg scale)
• Peptide modifications and labeling
• Small molecule synthesis
• Project-based research and scale-up

We work closely with our clients to ensure technical feasibility, fast delivery, and cost control throughout the development cycle.

3. Wide Product Portfolio

We supply a comprehensive and expanding product range:
• Peptides: GLP-1 analogs (e.g., Semaglutide, Tirzepatide, Retatrutide), cosmetic peptides (e.g., Acetyl Hexapeptide-8, Matrixyl), anti-aging peptides, research peptides.
• Small Molecules: Nootropics, NAD+ boosters (e.g., NMN, NR, NADH), and intermediates.
• Biochemicals: Amino acid derivatives, enzyme co-factors, custom reagents.

New products are launched regularly to meet evolving market needs. We also support batch reservations for clients with ongoing or seasonal demand.

Is tirzepatide available for weight loss?

It's also FDA approved for chronic weight management in adults with or without diabetes. Along with diet and exercise, tirzepatide can lead to significant weight loss — an average of 15% to 20% (34 lbs to 48 lbs). But tirzepatide for weight loss is only recommended for people who meet certain BMI criteria.

How fast do you lose weight on tirzepatide?

How quickly you lose weight depends on factors like lifestyle habits, diet, activity level, age, and other medications you may be taking. However, most people who follow a healthy diet and exercise routine begin reporting some weight loss within a month to two months of starting the medication.